Net negative change in calcium levels because of decreased intestinal absorption and increased urinary excretion of calcium.
Pain and tenderness at fracture site
Calcium reduces fracture risk by 34%.
Vit D supplementation reduces hip fracture risk by 10% and nonvertebral fracture risk by 7%.
High dose vitamin D (median, 800IU/d) reduces hip fractures by 24% and nonvertebral fractures by 30%.
T score <-2.5SD, fragility fracture of the hip, in both men and women
Alendronate reduces vertebral fractures by 48% and nonvertebral fractures by 47%.
Risedronate reduces vertebral fractures by 65% and nonvertebral fractures by 39%.
Ibrandronate reduces vetebralfracture risk by 77%, hip fractures by 41% and nonvertebral fractures by 15%.
pamidronate, alendronate (Fosamax), risedronate (Actonel), zolendronate (Reclast), ibandronate (Boniva)
Salmon calcitonin (Fortical or Miacalcin)
1-34 amino terminal residues of parathyroid hormone (1-84) ; given by daily subcutaneous injections (continuous infusion leads to bone resorption)
Transient hypercalcemia, dizziness, nausea, headache.
Contraindicated in Paget's disease due to potential osteosarcoma risk
Arthralgia, nasopharyngitis, back pain.
Contraindicated in severe hypocalcemia
Please rate topic.
Average 4.4 of 59 Ratings
Thank you for rating! Please vote below and help us build the most advanced adaptive learning platform in medicine
You have 100% on this question. Just skip this one for now.
A 72-year-old woman presents with severe hip pain after stepping off of a curb. She denies any trauma or prior history of hip pain. Her past medical history is reviewed including a list of her current medications. Which of the following of her medications would place her at increased risk for a non-traumatic hip fracture?
Select Answer to see Preferred Response
Which of the following pharmacologic treatments for osteoporosis has been associated with the potential risk for osteosarcoma development?
Non-nitrogen containing bisphosphonate
Monoclonal Ig2 against RANKL
Nitrogen containing bisphosphonates
Recombinant parathyroid hormone (1-34)
A 58-year-old woman falls down while walking her dog and sustains the low-energy injury shown in Figures A and B. Which of the following lab values is most likely to be abnormal in this patient?
25-hydroxy cholecalciferol (25 OH vitamin D)
Parathyroid hormone-related protein (PTHrP)
Sry-type high-mobility-group box transcription factor-9 (Sox-9)
LRP5 (low-density lipoprotein receptor-related protein)
A 55-year-old healthy female presents for a routine physical exam. In regards to bone health and osteoporosis prevention, what dose of calcium and vitamin D should be recommended for daily consumption?
1,500mg of calcium and 1,000 IUs of vitamin D
2,200mg of calcium and 1,000 IUs of vitamin D
750mg of calcium and 5,000 IUs of vitamin D
750mg of calcium and 10,000 IUs of vitamin D
2,200mg of calcium and 5,000 IUs of vitamin D
A 52-year old woman who is not on any hormone replacement therapy (HRT) falls from standing height and sustains the injury seen in Figure A. Review of her medical history reveals that she carries a diagnosis of osteoporosis, and that her latest T-score was -3.0. How much calcium should she have been consuming on a daily basis prior to sustaining her injury?
A 58-year-old female falls and sustains the injury shown in Figures A and B. Following surgical treatment of the fracture, which of the following is the most appropriate additional investigation?
MRI of the pelvis
CT scan of the pelvis
You are seeing a 13-year-old girl for asymptomatic flat feet and recommend observation. In educating this patient/family about general bone health, you recommend what amount of daily dietary calcium for your patient?
250mg - 500mg
500mg - 750mg
750mg - 1000mg
1000mg - 1500mg
over 1500mg per day
An 80 year-old female undergoes ORIF of her hip fracture without any complications. A hospitalist consult was obtained for medical clearance pre-operatively, and she was diagnosed with osteoporosis. Which of the following treatment scenarios will lead to the best management of the patient's osteoporosis?
Schedule a follow-up appointment with the patients primary care physician to initiate therapy
Order a physical therapy consult and initiate an exercise plan
Have the patient meet with a nutritionist to increase her calcium and vitamin D intake
Start bisphosphonates, and have the patient follow-up with her primary care physician
Perform a metabolic work-up as an inpatient, and set-up an appointment in an osteoporosis clinic
Which of the following administered substances leads to net bone resorption?
Zoledronic acid (Reclast) injection once per year
Teriparatide (Forteo) injection once daily
Alendronate (Fosamax) oral once weekly
Teriparatide (Forteo) continuous infusion for 2 weeks
Alendronate (Fosamax) oral once daily
Which of the following medications is a recombinant form of parathyroid hormone that has been found to stimulate new bone formation in patients with postmenopausal osteoporosis?
Zoledronic acid (Reclast)
Genetic polymorphisms in all of the following genes are associated with osteoporosis EXCEPT?
Vitamin D receptor
Type I collagen alpha-1 chain
Cartilage oligomeric matrix protein (COMP)
Risk factors for insufficiency fractures of the pelvic ring include all of the following EXCEPT:
Total hip replacement with constrained liner
Total hip replacement with ceramic bearings
A 45 year-old woman who has not reached menopause yet falls from a standing height and sustains a distal radius fracture. A DEXA scan reveals a T-score of -2.2. Which of the following treatments is indicated in this patient?
1,700 mg of calcium
1,200 mg of calcium
1,700 mg of vitamin D
1,200 mg of iron
1,700 mg of PTH
With aging, there is a greater loss of mechanical strength in which of the following types of bone?
Cortical bone more than trabecular bone
Trabecular bone more than cortical bone
Cortical bone and trabecular bone equally
Only trabecular bone
Only cortical bone
A 62-year-old woman with a bone mass density (BMD) T-score of -2.0 sustained a subcapital fracture of her hip. She is an avid tennis player, and history reveals no previous fractures. What is the most appropriate follow-up care?
Antiresorptive bisphosphonate medication
A repeat dual-energy x-ray absorptiometry scan (DEXA) and treatment if the T-score is less than -2.5
A repeat DEXA scan and treatment if the T-score is greater than -1.5
No treatment since the BMD is not in osteoporotic range
(PTH) taraparatide hormone followed by surgery
Which of the following is NOT included in the best management of a elderly female newly diagnosed with a fragility fracture?
Hip and spine densitometry
Laboratory analysis for secondary causes of osteoporosis
Administration of calcium 1,500 mg/day
Administration of Vitamin D 400 to 800 IU/day
Low protein diet
What effect does intermittent administration of parathyroid hormone have on bone?
All of the following medications have been associated with an increased risk of osteoporosis EXCEPT:
Selective serotonin reuptake inhibitors (SSRI)
Non-steroidal anti-inflammatories (NSAIDs)
A 63-year-old woman falls from standing and lands on her right hand. She complains of deformity and wrist pain. Radiographs are provided in Figure A. Following closed reduction, the patient inquires whether she has osteoporosis and if she is likely to have another fracture. In counselling the patient, which of the following is the strongest predictor for a future fracture from low energy trauma?
Bone mineral density T-score < -2.5
Low vitamin D levels
Family history of osteoporosis
History of a prior fragility fracture
Ten year history of oral prednisone use
Regarding bone densitometry, a T-score of -3.5 is defined as which of the following?
Age appropriate bone loss
None. One cannot make this diagnosis without further information.
Which of the following patients are at greatest risk of having a future vertebral fragility fracture?
Elderly female with prior hip fragility fracture
Elderly female with prior distal radius fragility fracture
Elderly female with prior T6 compression fragility fracture
Elderly female with a T-score of -3.0
Elderly female currently on hormone replacement therapy